A Study to Develop A Familial Hypercholesterolemia Identification REgistry (FHIRE)


About this study

The purpose of this study is to develop a registry of molecularly confirmed Familial Hypercholesterolemia (FH) cases in conjunction with the retrospective FHIRE study (IRB# 18-009654) in order to identify and offer genetic testing to Mayo Clinic patients with suspected FH.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Mayo Clinic patients with suspected Familial Hypercholesterolemia (FH).
  • Age ≥ 18 years.
  • LDL cholesterol ≥ 190 mg/dl.
  • Capable of providing informed consent.

Exclusion Criteria:

  • Lack of research authorization.
  • Unable to provide informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Iftikhar Kullo, M.D.

Open for enrollment

Contact information:

Iftikhar Kullo M.D.



More information


Publications are currently not available

Mayo Clinic Footer